SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-022535
Filing Date
2022-04-04
Accepted
2022-04-04 17:11:12
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4154
  Complete submission text file 0001209191-22-022535.txt   5498
Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Drapkin Kimberlee C (Reporting) CIK: 0001340881 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40551 | Film No.: 22803632

Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)